Experimental and therapeutic medicine最新文献

筛选
英文 中文
[Retracted] TIPE2 suppresses atherosclerosis by exerting a protective effect on macrophages via the inhibition of the Akt signaling pathway. 【回缩】TIPE2通过抑制Akt信号通路对巨噬细胞发挥保护作用,从而抑制动脉粥样硬化。
Experimental and therapeutic medicine Pub Date : 2024-12-16 eCollection Date: 2025-02-01 DOI: 10.3892/etm.2024.12782
Dan Li, Ying Tan
{"title":"[Retracted] TIPE2 suppresses atherosclerosis by exerting a protective effect on macrophages via the inhibition of the Akt signaling pathway.","authors":"Dan Li, Ying Tan","doi":"10.3892/etm.2024.12782","DOIUrl":"https://doi.org/10.3892/etm.2024.12782","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.3892/etm.2019.7316.].</p>","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"29 2","pages":"32"},"PeriodicalIF":0.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12141992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of tigecycline for post‑neurosurgical intracranial infections due to MDR/XDR Acinetobacter baumannii: A retrospective cohort study. 静脉加鞘内/脑室注射替加环素治疗多耐药/广耐药鲍曼不动杆菌所致神经外科术后颅内感染的疗效:一项回顾性队列研究
Experimental and therapeutic medicine Pub Date : 2024-12-13 eCollection Date: 2025-02-01 DOI: 10.3892/etm.2024.12781
Xia Tian, Xianbing Meng, Lichao Guo, Yan Li, Guoqing Gu, Tianyan Zhang, Rufeng An
{"title":"Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of tigecycline for post‑neurosurgical intracranial infections due to MDR/XDR <i>Acinetobacter baumannii</i>: A retrospective cohort study.","authors":"Xia Tian, Xianbing Meng, Lichao Guo, Yan Li, Guoqing Gu, Tianyan Zhang, Rufeng An","doi":"10.3892/etm.2024.12781","DOIUrl":"10.3892/etm.2024.12781","url":null,"abstract":"<p><p>Intracranial infection is a complication of neurosurgery that can lead to severe neurological complications, greatly increasing the risk of mortality. Intracranial infection caused by multidrug-resistant <i>Acinetobacter baumannii</i> (MDR-AB) is one of the most severe complications of craniotomy. However, the availability of effective therapeutic options for such infections remains limited. Therefore, the present study aimed to assess the therapeutic efficacy of intrathecal/intracerebral (ITC) ventricle tigecycline injection for managing post-neurosurgical intracranial infections caused by MDR-AB. The present retrospective study was conducted from January 2014 to December 2023 at the Second Affiliated Hospital of Shandong First Medical University (Taian, China), which included 15 cases of MDR-AB positivity in the cerebrospinal fluid (CSF) cultures after neurosurgery. Patients treated with intravenous and intrathecal/ITC tigecycline ventricle injection were assigned to the 'ITV + ITC' group, whereas patients treated without intrathecal/ITC injection were assigned to the 'ITV' group. Data for general information, treatment history, the results of biochemical indicators in CSF and the microbiological clearance rate were collected and analyzed. No significant differences were observed in characteristics, susceptibility testing or empirical antimicrobial use between the two groups after treatment. However, after treatment, the ITV + ITC group exhibited a significantly decreased body temperature, whilst the biochemical indicators present in CSF were significantly improved. In addition, the ITV + ITC group had a significantly higher microbiological clearance rate (5/6; 83.33%) compared with that in the ITV group (2/9; 22.22%). These findings suggest that intravenous plus intrathecal/ITC ventricle injection of tigecycline is an effective regimen for treating intracranial infections caused by MDR-AB.</p>","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"29 2","pages":"31"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12141990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blockade of cysteinyl leukotriene receptor 1 alleviates asthma by inhibiting bronchial epithelial cell apoptosis and activating the Nrf2 signaling pathway. 阻断半胱氨酸白三烯受体1通过抑制支气管上皮细胞凋亡和激活Nrf2信号通路缓解哮喘。
Experimental and therapeutic medicine Pub Date : 2024-12-13 eCollection Date: 2025-02-01 DOI: 10.3892/etm.2024.12780
Xiangjie Wu, Yiqiong Chen, Suping Chen, Yiping Lin
{"title":"Blockade of cysteinyl leukotriene receptor 1 alleviates asthma by inhibiting bronchial epithelial cell apoptosis and activating the Nrf2 signaling pathway.","authors":"Xiangjie Wu, Yiqiong Chen, Suping Chen, Yiping Lin","doi":"10.3892/etm.2024.12780","DOIUrl":"10.3892/etm.2024.12780","url":null,"abstract":"<p><p>The therapeutic role of blockade of cysteinyl leukotriene receptor 1 (CysLTR1) in asthma has been previously studied. However, the effect of CysLTR1 blockade on bronchial epithelial cell apoptosis and the nuclear factor erythroid-derived 2-related factor 2 (Nrf2) signaling pathway remains unclear. The present study established an ovalbumin (OVA)-induced asthmatic rat model. Varying doses (1, 4 and 30 mg/kg) of montelukast sodium, a specific CysLTR1 antagonist, were used to inhibit CysLTR1 function in an asthmatic rat model. Reverse transcription-quantitative PCR was used to detect the expression levels of CysLTR1, NAD(P)H quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HO-1). CysLTR1 and Nrf2 protein expression levels were determined using western blotting. Immunofluorescence assays were used to evaluate the relative fluorescence intensity of Nrf2 in rat lung tissues. Lung tissue histology was assessed through hematoxylin & eosin, alcian blue and periodic acid-Schiff and Masson's trichrome staining assays. The levels of IL-17, IL-4, serum IgE and the reduced/oxidized glutathione ratio were determined using ELISA assay kits. The number of inflammatory cells was analyzed using Wright-Giemsa staining. Bronchial epithelial cell apoptosis was measured using a TUNEL assay. The results indicated that OVA-induced inflammatory responses and increased eosinophil, lymphocyte and macrophage counts were significantly attenuated following blockade of CysLTR1. Downregulated expression of antioxidant genes NQO1 and HO-1 and the reduced GSH/GSSG ratio caused by OVA challenge were restored by blockade of CysLTR1. Additionally, CysLTR1 blockade also reduced collagen deposition, suppressed goblet cell hyperplasia and inhibited bronchial epithelial cell apoptosis in a rat model of asthma. Furthermore, it was demonstrated that the blockade of CysLTR1 could significantly increase Nrf2 expression. In conclusion, the blockade of CysLTR1 could alleviate asthma in an OVA-induced rat model by inhibiting bronchial epithelial cell apoptosis and activating the Nrf2 signaling pathway. These data may potentially provide a theoretical basis for future asthma therapy in a clinical setting.</p>","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"29 2","pages":"30"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12141991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SEfficacy and safety of apatinib in the treatment of patients with platinum‑resistant ovarian cancer: A systematic review and network meta‑analysis 阿帕替尼治疗铂类耐药卵巢癌患者的疗效和安全性:系统综述与网络荟萃分析
Experimental and therapeutic medicine Pub Date : 2024-07-26 DOI: 10.3892/etm.2024.12665
Wei Wang, Fayong Liu, Shan Qiu, Yan Jiao, Yanfei Zhu
{"title":"SEfficacy and safety of apatinib in the treatment of patients with platinum‑resistant ovarian cancer: A systematic review and network meta‑analysis","authors":"Wei Wang, Fayong Liu, Shan Qiu, Yan Jiao, Yanfei Zhu","doi":"10.3892/etm.2024.12665","DOIUrl":"https://doi.org/10.3892/etm.2024.12665","url":null,"abstract":"","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"27 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141800570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between preterm delivery and the risk of maternal renal disease: A systematic review and meta‑analysis 早产与产妇肾病风险之间的关系:系统回顾和荟萃分析
Experimental and therapeutic medicine Pub Date : 2024-07-26 DOI: 10.3892/etm.2024.12667
Wenting Wu, Yingying Chen, Xiaoxing Zhang, Qing Zhu, Qilong Shen
{"title":"Association between preterm delivery and the risk of maternal renal disease: A systematic review and meta‑analysis","authors":"Wenting Wu, Yingying Chen, Xiaoxing Zhang, Qing Zhu, Qilong Shen","doi":"10.3892/etm.2024.12667","DOIUrl":"https://doi.org/10.3892/etm.2024.12667","url":null,"abstract":"","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"27 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141801805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified reconstruction approach after pancreaticoduodenectomy optimizes postoperative outcomes: Results from a multivariate cohort analysis 胰十二指肠切除术后的改良重建方法可优化术后效果:多变量队列分析结果
Experimental and therapeutic medicine Pub Date : 2024-07-26 DOI: 10.3892/etm.2024.12666
Stavros Parasyris, Vasiliki Ntella, Theodoros A. Sidiropoulos, Stefanos A. Maragkos, N. Pantazis, P. Patapis, P. Matsota, P. Vassiliu, Vasileios Smyrniotis, Nikolaos Arkadopoulos
{"title":"Modified reconstruction approach after pancreaticoduodenectomy optimizes postoperative outcomes: Results from a multivariate cohort analysis","authors":"Stavros Parasyris, Vasiliki Ntella, Theodoros A. Sidiropoulos, Stefanos A. Maragkos, N. Pantazis, P. Patapis, P. Matsota, P. Vassiliu, Vasileios Smyrniotis, Nikolaos Arkadopoulos","doi":"10.3892/etm.2024.12666","DOIUrl":"https://doi.org/10.3892/etm.2024.12666","url":null,"abstract":"","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"29 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141799401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Corrigendum] ACSM3 suppresses proliferation and induces apoptosis and cell cycle arrest in acute myeloid leukemia cells via the regulation of IGF2BP2 [更正] ACSM3通过调控IGF2BP2抑制急性髓性白血病细胞的增殖并诱导其凋亡和细胞周期停滞
Experimental and therapeutic medicine Pub Date : 2024-07-25 DOI: 10.3892/etm.2024.12663
Xin Zheng, Jinjun Wu, Linlan Song, Bo Huang
{"title":"[Corrigendum] ACSM3 suppresses proliferation and induces apoptosis and cell cycle arrest in acute myeloid leukemia cells via the regulation of IGF2BP2","authors":"Xin Zheng, Jinjun Wu, Linlan Song, Bo Huang","doi":"10.3892/etm.2024.12663","DOIUrl":"https://doi.org/10.3892/etm.2024.12663","url":null,"abstract":"","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"12 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141803346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
N6‑methyladenosine methyltransferase METTL14 is associated with macrophage polarization in rheumatoid arthritis N6-甲基腺苷甲基转移酶 METTL14 与类风湿性关节炎的巨噬细胞极化有关
Experimental and therapeutic medicine Pub Date : 2024-07-25 DOI: 10.3892/etm.2024.12664
Ziheng Zhu, Lei Wan
{"title":"N6‑methyladenosine methyltransferase METTL14 is associated with macrophage polarization in rheumatoid arthritis","authors":"Ziheng Zhu, Lei Wan","doi":"10.3892/etm.2024.12664","DOIUrl":"https://doi.org/10.3892/etm.2024.12664","url":null,"abstract":"","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"36 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141805983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of telitacicept in patients with lupus nephritis 替立替塞肽对狼疮性肾炎患者的疗效和安全性
Experimental and therapeutic medicine Pub Date : 2024-07-23 DOI: 10.3892/etm.2024.12660
Hong Zhu, Hui-Qian Hu, Hui-Ling Wei, De-Xin Zhang, Hua Yang, Qian-kun Zhang, Lie Jin
{"title":"Efficacy and safety of telitacicept in patients with lupus nephritis","authors":"Hong Zhu, Hui-Qian Hu, Hui-Ling Wei, De-Xin Zhang, Hua Yang, Qian-kun Zhang, Lie Jin","doi":"10.3892/etm.2024.12660","DOIUrl":"https://doi.org/10.3892/etm.2024.12660","url":null,"abstract":"","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"111 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141811814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interference of FZD2 suppresses proliferation, vasculogenic mimicry and stemness in glioma cells via blocking the Notch/NF‑κB signaling pathway 干扰FZD2可通过阻断Notch/NF-κB信号通路抑制胶质瘤细胞的增殖、血管生成模拟和干细胞形成
Experimental and therapeutic medicine Pub Date : 2024-07-23 DOI: 10.3892/etm.2024.12662
Yuge Ran, Shuai Han, Dongxue Gao, Xiaobo Chen, Chan Liu
{"title":"Interference of FZD2 suppresses proliferation, vasculogenic mimicry and stemness in glioma cells via blocking the Notch/NF‑κB signaling pathway","authors":"Yuge Ran, Shuai Han, Dongxue Gao, Xiaobo Chen, Chan Liu","doi":"10.3892/etm.2024.12662","DOIUrl":"https://doi.org/10.3892/etm.2024.12662","url":null,"abstract":"","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"16 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141810027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信